Lake Street Capital started coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a research report report published on Wednesday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $20.00 price objective on the stock.
Several other equities research analysts also recently commented on AVR. Barclays initiated coverage on Anteris Technologies Global in a report on Tuesday. They set an “overweight” rating and a $22.00 price objective for the company. TD Cowen assumed coverage on Anteris Technologies Global in a report on Tuesday. They issued a “buy” rating and a $15.00 target price on the stock. Finally, Cantor Fitzgerald started coverage on Anteris Technologies Global in a report on Tuesday. They set an “overweight” rating and a $9.00 price target for the company.
View Our Latest Stock Report on Anteris Technologies Global
Anteris Technologies Global Stock Performance
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Read More
- Five stocks we like better than Anteris Technologies Global
- Retail Stocks Investing, Explained
- Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Your Best Trading Year Starts Here: Top 3 Stocks for 2025 Gains
- What is the S&P/TSX Index?
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.